Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Development & Trend
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
Company (Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Fine Chemicals Corporation, Fine Chemicals Corporation, Hengtengfu Biological Products, Vinkem etc.):
Product & Service
Business Operation Data